News

Beta-thalassemia results from mutations of the β-hemoglobin (Hbb) gene and reduced functional Hbb synthesis. Excess α-Hb causes globin chain aggregation, oxidation, cytoskeletal damage, and increased ...
"Vertex reports long-term results for Casgevy in sickle cell and thalassaemia" was originally created and published by ...
In people with beta-thalassaemia, osteoporosis represents an important cause of morbidity and is due to a number of factors. First, ineffective erythropoiesis causes bone marrow expansion, leading to ...
Thalassemia is viewed as a prevalent inherited blood disease that has gotten exorbitant consideration in the field of medical research around the world. Inherited diseases have a high risk that ...
Don't download beta software, which will likely have bugs and glitches, on your everyday iPhone. Beta versions are released so you can test new features and share feedback to improve iOS.
The PGA Tour announced that Jordan Spieth has withdrawn from the Travelers Championship due to an injury. This is the first time in 297 starts that Speith has withdrawn from a PGA Tour event. A video ...
U.S. Director of National Intelligence Tulsi Gabbard rescheduled a briefing on Wednesday for the U.S. Senate intelligence committee because of the situation in Iran, a spokesperson for the panel's ...
The City of Lawton and U.S. Army Fort Sill announced Thursday evening the cancellation of this year’s Army Birthday Parade due to what they say are credible security threats.
Liquid Glass brings a new, refreshed look to iOS 26, but it inadvertently changes the way Control Center looks. Here's the first thing I did to change that.
As you may already know by now, Apple announced iOS 26 at its WWDC keynote this past Monday. This version of iOS contain tons of new features including an all-new Liquid Glass design, new features for ...
Attorneys for Kilmar Abrego Garcia argue for ‘due process’ in new court filing by: Jessica Barker Posted: Jun 11, 2025 / 07:21 PM CDT Updated: Jun 12, 2025 / 06:19 AM CDT ...
These data validate the further development of Editas' proprietary HSC-tLNP for editing of the HBG1/2 promoters for the treatment of sickle cell disease and beta thalassemia,” said Linda C ...